Skip to content
Recall Observatory FDA recall evidence

Drug product

Nicardipine Hydrochloride Injection 25 mg/10 mL (2.5 mg/mL), 10 mL single-use vials, Rx Only, Mfd. by Exela Pharma Sciences, LLC, Lenoir, NC, Dist. by: West-ward Pharmaceutical Corp., Eatontown, NJ --- NDC 0143-9689-10

D-691-2013

May 13, 2013

Class III

Product summary

Firm
West-ward Pharmaceutical Corp.
Event
Event 65287
Status
Terminated
Classification
Class III
Quantity
Lot PLNJ1201 -16,880 vials ; Lot PLNJ1202 - 16,960 vials
Official record key
drug-enforcement:D-691-2013

Official wording

Reason: Failed Impurity/Degradation Specifications; out of specification value for impurity Nitrophenylpuridine Derivative (NPP-D)

Code information: Lot PLNJ1201 APRIL 2014 Lot PLNJ1202 MAY 2014

Distribution pattern: Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out of specification